Staff use of UCL’s Research Publication Service (RPS).

Important: Some staff members in the Cancer Institute are currently participating in an internal assessment exercise in preparation for REF2021 (Research Excellence Framework 2021).

13 June 2018

Only staff who are eligible for return to REF2021 are taking part in this exercise, and these staff members will have been contacted separately by an email from me, and/or via their Division or Institute manager or REF lead, requesting their participation.

You should only take part in this exercise if you have received an email identifying you as eligible for return to REF 2021 and requesting you to submit outputs using UCL’s Research Publication Service (RPS).

If, when you log in to RPS, you see as one your actions “Start your REF Internal Assessment (UoA1) assessment”, pleasedo NOT respond to this request unless you have already been contacted by email asking you to do so. If you are in any doubt, please contact your Division or Institute REF lead (CI: Richard Jenner) or Manager, or contact me i.zachary@ucl.ac.uk

Best wishes

Ian Zachary
Professor of Vascular Cell Biology
Vice-Dean Research, Faculty of Medical Sciences
Lead for REF2021 UoA1.

Highlights in Medical Sciences

Drug to treat aggressive leukaemia approved for use in adults

Research

Drug to treat aggressive leukaemia approved for use in adults

Adult patients with aggressive leukaemia will soon be able to receive a breakthrough immunotherapy, developed by UCL researchers, on the NHS after approval by NICE.

Millions could benefit from faster prostate cancer scan

Research

Millions could benefit from faster prostate cancer scan

Results of the PRIME trial involving UCL Medical Sciences researchers have found that a quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan.

UCL Cancer Institute awarded Athena SWAN Gold

Award

UCL Cancer Institute awarded Athena SWAN Gold

The UCL Cancer Institute has been awarded Athena SWAN Gold in recognition of its sustained commitment to advancing gender equality in higher education and research.